Literature DB >> 2223628

Induction of patching and its reversal on surface-activated human platelets.

J G White1.   

Abstract

Fibrinogen coupled to colloidal gold (Fgn/Au) has been used to follow GPIIb-IIIa receptors on surface-activated platelets and to evaluate the effects of the anti-actin agent, cytochalasin B (CB), on the movement of receptor-ligand complexes. Fgn/Au binds diffusely to spread platelets, but is translocated rapidly from the peripheral margin to cell centres and to channels of the open canalicular system (OCS). CB added after spreading and incubation with Fgn/Au reverses the centripetal movement of receptor-ligand complexes. Fgn/Au particles move back toward the margins of spread cells and form patches. The patches of receptor-ligand complexes overlie segments of the OCS filled with Fgn/Au. Washing out the CB reverses the process and receptor-ligand complexes are again translocated toward platelet centres.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2223628     DOI: 10.1111/j.1365-2141.1990.tb07844.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  3 in total

1.  Dynamic redistribution of major platelet surface receptors after contact-induced platelet activation and spreading. An immunoelectron microscopy study.

Authors:  N Kieffer; J Guichard; J Breton-Gorius
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

2.  Absence of ligands bound to glycoprotein IIB-IIIA on the exposed surface of a thrombus may limit thrombus growth in flowing blood.

Authors:  H F Heynen; M Lozano Molero; P G de Groot; H K Nieuwenhuis; J J Sixma
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

3.  Activation-dependent changes in human platelet PECAM-1: phosphorylation, cytoskeletal association, and surface membrane redistribution.

Authors:  P J Newman; C A Hillery; R Albrecht; L V Parise; M C Berndt; A V Mazurov; L C Dunlop; J Zhang; S E Rittenhouse
Journal:  J Cell Biol       Date:  1992-10       Impact factor: 10.539

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.